skip to main content
Idioma:
Resultados 1 2 next page
Refinado por: Nome da Publicação: Blood remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Maciejewski, Jaroslaw P. ; Follmann, Dean ; Nakamura, Ryotaro ; Saunthararajah, Yogen ; Rivera, Candido E. ; Simonis, Toni ; Brown, Kevin E. ; Barrett, John A. ; Young, Neal S.

Blood, 2001-12, Vol.98 (13), p.3513-3519 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
2
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation

Takahashi, Yoshiyuki ; McCoy, J. Philip Jr ; Carvallo, Cristian ; Rivera, Candido ; Igarashi, Takehito ; Srinivasan, Ramaprasad ; Young, Neal S. ; Childs, Richard W.

Blood, 2004-02, Vol.103 (4), p.1383-1390 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Assessment and Monitoring of Constitutional Symptoms in Patients with Myelofibrosis: A Proposed New Instrument the Myelofibrosis Symptom Assessment Form (MFSAF)
Assessment and Monitoring of Constitutional Symptoms in Patients with Myelofibrosis: A Proposed New Instrument the Myelofibrosis Symptom Assessment Form (MFSAF)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessment and Monitoring of Constitutional Symptoms in Patients with Myelofibrosis: A Proposed New Instrument the Myelofibrosis Symptom Assessment Form (MFSAF)

Mesa, Ruben A. ; Schwager, Susan ; Radia, Deepti ; Cheville, Andrea ; Hussein, Kebede ; Niblack, Joyce ; Pardanani, Animesh D. ; Steensma, David P. ; Litzow, Mark R. ; Rivera, Candido E. ; Camoriano, John ; Verstovsek, Srdan ; Sloan, Jeffrey ; Harrison, Claire ; Tefferi, Ayalew

Blood, 2008-11, Vol.112 (11), p.1754-1754 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
4
Phase II Study of Melphalan, Prednisone and Lenalidomide Combination for Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation
Phase II Study of Melphalan, Prednisone and Lenalidomide Combination for Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Study of Melphalan, Prednisone and Lenalidomide Combination for Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation

Roy, Vivek ; Stewart, A. Keith ; Bergsagel, P. Leif ; Dispenzieri, Angela ; Laumann, Kristina ; Allred, Jake ; Lacy, Martha Q. ; Fonseca, Rafael ; Reeder, Craig B. ; Kumar, Shaji ; Rivera, Candido E. ; Gertz, Morie A. ; Greipp, Philip R. ; Buadi, Francis K. ; Hayman, Suzanne R. ; Rajkumar, S. Vincent

Blood, 2008-11, Vol.112 (11), p.2769-2769 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

Cortes, Jorge ; Lipton, Jeff H. ; Rea, Delphine ; Digumarti, Raghunadharao ; Chuah, Charles ; Nanda, Nisha ; Benichou, Annie-Claude ; Craig, Adam R. ; Michallet, Mauricette ; Nicolini, Franck E. ; Kantarjian, Hagop

Blood, 2012-09, Vol.120 (13), p.2573-2580 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Allogeniec Stem Cell Transplantation for Primary and Post ET/PV Myelofibrosis At Mayo Clinic: A Retrospective Review Across a Geographically Diverse 3 Site Cancer Center
Allogeniec Stem Cell Transplantation for Primary and Post ET/PV Myelofibrosis At Mayo Clinic: A Retrospective Review Across a Geographically Diverse 3 Site Cancer Center
Material Type:
Artigo 		Adicionar ao Meu Espaço

Allogeniec Stem Cell Transplantation for Primary and Post ET/PV Myelofibrosis At Mayo Clinic: A Retrospective Review Across a Geographically Diverse 3 Site Cancer Center

Fauble, Veena Devi Salem ; Slack, James L ; Hogan, William ; Roy, Vivek ; Leis, Jose ; Dueck, Amylou C. ; Litzow, Mark R ; Patnaik, Mrinal M. ; Animesh, Pardanani ; Rivera, Candido E. ; Tibes, Raoul ; Camoriano, John ; Adams, Roberta H. ; Noel, Pierre ; Khera, Nandita ; Sproat, Lisa ; Mesa, Ruben A.

Blood, 2012-11, Vol.120 (21), p.2850-2850 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
Combination of Lenalidomide with R-CHOP (R2CHOP) Is Well-Tolerated and Effective As Initial Therapy for Aggressive B-Cell Lymphomas - A Phase II Study
Combination of Lenalidomide with R-CHOP (R2CHOP) Is Well-Tolerated and Effective As Initial Therapy for Aggressive B-Cell Lymphomas - A Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of Lenalidomide with R-CHOP (R2CHOP) Is Well-Tolerated and Effective As Initial Therapy for Aggressive B-Cell Lymphomas - A Phase II Study

Nowakowski, Grzegorz S. ; LaPlant, Betsy R. ; Reeder, Craig ; Foran, James M. ; Porrata, Luis F. ; Macon, William R ; Johnston, Patrick B. ; Rivera, Candido E. ; Habermann, Thomas M ; Inwards, David J. ; Micallef, Ivana N. ; Nelson, Garth D ; Ansell, Stephen M. ; Witzig, Thomas E.

Blood, 2012-11, Vol.120 (21), p.689-689 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
8
Interference Of The Tumor Supportive Effects Of BCL2 and MCL1 Sensitize Malignant Plasma Cells To The Lethal Effects Of Lenalidomide and Dexamethasone Regimen: An Important Clinical Path For BCL2 Targeting Drugs
Interference Of The Tumor Supportive Effects Of BCL2 and MCL1 Sensitize Malignant Plasma Cells To The Lethal Effects Of Lenalidomide and Dexamethasone Regimen: An Important Clinical Path For BCL2 Targeting Drugs
Material Type:
Artigo 		Adicionar ao Meu Espaço

Interference Of The Tumor Supportive Effects Of BCL2 and MCL1 Sensitize Malignant Plasma Cells To The Lethal Effects Of Lenalidomide and Dexamethasone Regimen: An Important Clinical Path For BCL2 Targeting Drugs

Paulus, Aneel ; Chitta, Kasyapa S. ; Akhtar, Sharoon ; Kuranz, Maja ; Kumar, Shaji ; Roy, Vivek ; Ansell, Stephen M. ; Mikhael, Joseph R. ; Dispenzieri, Angela ; Reeder, Craig ; Rivera, Candido E. ; Foran, James M. ; Buadi, Francis ; Rajkumar, Vincent ; Chanan-Khan, Asher

Blood, 2013-11, Vol.122 (21), p.1928-1928 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
9
Phase 2 Trial Of Single Agent MLN9708 In Patients With Relapsed Multiple Myeloma Not Refractory To Bortezomib
Phase 2 Trial Of Single Agent MLN9708 In Patients With Relapsed Multiple Myeloma Not Refractory To Bortezomib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 Trial Of Single Agent MLN9708 In Patients With Relapsed Multiple Myeloma Not Refractory To Bortezomib

Kumar, Shaji K ; Roy, Vivek ; Reeder, Craig ; LaPlant, Betsy R. ; Lacy, Martha Q ; Gertz, Morie A ; Laumann, Kristina ; Thompson, Melanie Ann ; Witzig, Thomas E ; Buadi, Francis K ; Rivera, Candido E. ; Mikhael, Joseph R. ; Bergsagel, Peter Leif ; Hwa, Lisa ; Rajkumar, S. Vincent ; Dispenzieri, Angela

Blood, 2013-11, Vol.122 (21), p.1944-1944 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
Phase I/II Clinical Trial of Lenalidomide in Combination with AT101 for the Treatment of Relapsed B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Phase I/II Clinical Trial of Lenalidomide in Combination with AT101 for the Treatment of Relapsed B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I/II Clinical Trial of Lenalidomide in Combination with AT101 for the Treatment of Relapsed B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Paulus, Aneel ; Advani, Pooja ; Laplant, Betsy R. ; Akhtar, Sharoon ; Sher, Taimur ; Rivera, Candido E. ; Foran, James M. ; Roy, Vivek ; Colon-Otero, Gerardo ; Ailawadhi, Sikander ; Chanan-Khan, Asher Alban

Blood, 2015-12, Vol.126 (23), p.5299-5299 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.